Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2013 00:12 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Fourth Quarter and Full Year 2012 Operating and Financial Results

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results...
February 28, 2013 00:10 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Fourth Quarter and Full Year 2012 Operating and Financial Results

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results...
February 12, 2013 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement

IMMUNE TO PROVIDE EPICEPT WITH UP TO $0.5 MILLION IN WORKING CAPITAL HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Immune...
October 02, 2012 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Third Quarter 2012 Results

TORONTO, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
August 09, 2012 07:47 ET | Source: AstraZeneca PLC

ASTRAZENECA AND BRISTOL-MYERS SQUIBB COMPLETE EXPANSION OF DIABETES ALLIANCE THROUGH BRISTOL-MYERS SQUIBB’S ACQUISITION OF AMYLIN PHARMACEUTICALS

9 August 2012 AstraZeneca and Bristol-Myers Squibb today announced that following the successful completion of the acquisition of Amylin Pharmaceuticals by Bristol -Myers Squibb, AstraZeneca has made...
July 31, 2012 08:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Settles Patent Litigation With AstraZeneca Concerning Generic Seroquel XR(R)

TORONTO, July 31, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
July 02, 2012 02:26 ET | Source: AstraZeneca PLC

BRISTOL-MYERS SQUIBB AND ASTRAZENECA EXPAND DIABETES ALLIANCE THROUGH BRISTOL-MYERS SQUIBB’S ACQUISITION OF AMYLIN PHARMACEUTICALS

Strengthens leadership position of successful alliance in growing area of high unmet medical need Complements current portfolio creating a more comprehensive disease management platform with the...
June 26, 2012 11:00 ET | Source: ACT Foundation of Canada

Students in All York Region High Schools to Receive Lifesaving Training!

YORK REGION, ONTARIO--(Marketwire - June 26, 2012) - Today, the Advanced Coronary Treatment (ACT) Foundation, in partnership with the Government of Ontario, The Ontario Trillium...
May 29, 2012 07:00 ET | Source: ACT Foundation of Canada

CPR Flash Mob Sees Students Demonstrate Lifesaving Skill to Fellow Students

MISSISSAUGA, ONTARIO--(Marketwire - May 29, 2012) - Students at Our Lady of Mount Carmel Secondary School in Mississauga, Ontario, today flash mobbed 1,000 of their classmates, teaching...
May 15, 2012 07:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Fiscal 2012 First Quarter Results

WALTHAM, Mass., May 15, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the first quarter of fiscal year 2012 and provided a...